JP2012092110A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092110A5
JP2012092110A5 JP2011256721A JP2011256721A JP2012092110A5 JP 2012092110 A5 JP2012092110 A5 JP 2012092110A5 JP 2011256721 A JP2011256721 A JP 2011256721A JP 2011256721 A JP2011256721 A JP 2011256721A JP 2012092110 A5 JP2012092110 A5 JP 2012092110A5
Authority
JP
Japan
Prior art keywords
cancer
use according
treatment
subject
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011256721A
Other languages
English (en)
Japanese (ja)
Other versions
JP5421340B2 (ja
JP2012092110A (ja
Filing date
Publication date
Priority claimed from MYPI20003987A external-priority patent/MY138883A/en
Application filed filed Critical
Publication of JP2012092110A publication Critical patent/JP2012092110A/ja
Publication of JP2012092110A5 publication Critical patent/JP2012092110A5/ja
Application granted granted Critical
Publication of JP5421340B2 publication Critical patent/JP5421340B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011256721A 2000-08-29 2011-11-24 癌治療のためのアジア酸またはアジアチコサイドの使用。 Expired - Fee Related JP5421340B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20003987 2000-08-29
MYPI20003987A MY138883A (en) 2000-08-29 2000-08-29 Use of asiatic acid for treatment of cencer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002522878A Division JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。

Publications (3)

Publication Number Publication Date
JP2012092110A JP2012092110A (ja) 2012-05-17
JP2012092110A5 true JP2012092110A5 (https=) 2013-04-04
JP5421340B2 JP5421340B2 (ja) 2014-02-19

Family

ID=19749475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002522878A Pending JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。
JP2011256721A Expired - Fee Related JP5421340B2 (ja) 2000-08-29 2011-11-24 癌治療のためのアジア酸またはアジアチコサイドの使用。

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002522878A Pending JP2004507496A (ja) 2000-08-29 2001-02-14 癌治療のためのアジア酸またはアジアチコサイドの使用。

Country Status (9)

Country Link
US (1) US20040097463A1 (https=)
EP (1) EP1313462B1 (https=)
JP (2) JP2004507496A (https=)
AT (1) ATE415962T1 (https=)
AU (1) AU2001247968A1 (https=)
DE (1) DE60136826D1 (https=)
DK (1) DK1313462T3 (https=)
MY (1) MY138883A (https=)
WO (1) WO2002017904A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144312A1 (en) * 2001-10-30 2003-07-31 Schoenhard Grant L. Inhibitors of ABC drug transporters in multidrug resistant cancer cells
KR100571886B1 (ko) 2004-02-23 2006-04-17 학교법인 영남학원 아시아틱산을 포함하는 피부암 예방 또는 치료용 조성물
WO2005082415A2 (en) * 2004-02-25 2005-09-09 Dana Farber Cancer Institute, Inc. Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
CA2595749A1 (en) * 2005-01-27 2006-08-03 Research Development Foundation Combination therapy with triterpenoid compounds and proteasome inhibitors
CN101969942A (zh) * 2008-01-11 2011-02-09 上海医药工业研究院 基于积雪草酸及其特定盐的治疗剂
ES2836128T3 (es) 2008-04-16 2021-06-24 Univ Johns Hopkins Método para determinar variantes del receptor de andrógenos en cáncer de próstata
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
BR112012015130B1 (pt) 2009-12-21 2020-04-07 Pirelli processo para construir pneus, e, instalação para construir pneus para rodas de veículos
AU2010354973B2 (en) * 2010-06-10 2015-01-22 Indus Biotech Private Limited A method for preparation of highly pure asiaticoside composition from Centella asiatica and a method of use thereof
JP6091431B2 (ja) * 2011-01-31 2017-03-15 ルコラス−エム.ディー.リミテッド 医薬的使用
US20140194368A1 (en) * 2013-01-04 2014-07-10 Beech Tree Labs, Inc. Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)
RU2015137617A (ru) 2013-03-14 2017-04-18 Юниверсити Оф Мэриленд, Балтимор Офис Оф Текнолоджи Трансфер Агенты, подавляющие андрогенные рецепторы, и их применение
BR122020023215B1 (pt) * 2013-05-03 2022-11-22 Selecta Biosciences, Inc Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
CN105636594A (zh) 2013-08-12 2016-06-01 托凯药业股份有限公司 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物
WO2015179404A1 (en) 2014-05-19 2015-11-26 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
CA2959336A1 (en) * 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
EP3124047A1 (en) * 2015-07-28 2017-02-01 Merz Pharma GmbH & Co. KGaA Pentacyclic triterpenoids for injection lipolysis
CN108057034A (zh) * 2016-11-09 2018-05-22 香港中文大学 柚皮素和积雪草酸组合治疗癌症
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
WO2019200585A1 (en) * 2018-04-19 2019-10-24 The Chinese University Of Hong Kong Naringenin and asiatic acid combination treatment of cancers
EP3867280A4 (en) * 2018-10-18 2022-11-09 Sinomab Bioscience Limited METHODS OF TREATMENT OF RHEUMATOID ARTHRITIS
CN109528735B (zh) * 2019-01-30 2021-03-12 中国药科大学 积雪草苷在制备治疗皮肤癌药物中的新用途
AU2020287627A1 (en) 2019-06-04 2021-11-18 Selecta Biosciences, Inc. Formulations and doses of PEGylated uricase
CN110200981A (zh) * 2019-06-06 2019-09-06 中国药科大学 五环三萜皂苷的医药用途及其药物组合物
WO2022040341A1 (en) * 2020-08-20 2022-02-24 The Board Of Trustees Of The Leland Stanford Junior University Abscopal therapy for cancer
US20250275978A1 (en) * 2024-03-04 2025-09-04 Cardiff Oncology, Inc. Use of onvansertib as monotherapy and in combination with cetuximab in treating ras wild-type colorectal cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB923414A (en) * 1960-04-13 1963-04-10 Laroche Navarron Lab Therapeutic compositions comprising asiatic and arjunolic acids
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
FR2714598B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition amincissante à deux types de liposomes pour traitement topique, son utilisation.
JPH08133952A (ja) * 1994-11-07 1996-05-28 Shiseido Co Ltd 皮膚外用剤
JP2001504515A (ja) * 1996-11-27 2001-04-03 ドング クック ファーマシューティカル シーオー.,エルティーディー. 変形a環を有するアシアト酸誘導体
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
FR2763336B1 (fr) * 1997-05-14 1999-08-06 Lvmh Rech Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
WO2005120495A1 (en) * 2004-06-14 2005-12-22 Salama Zoser B Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody

Similar Documents

Publication Publication Date Title
JP2012092110A5 (https=)
JP2013525444A5 (https=)
WO2014004902A3 (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
BR112014003225A2 (pt) profármacos de treprostinil ligados a veículo
CN104024227B8 (zh) 抑制脯氨酸羟化酶活性的化合物的晶型及其应用
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
JO3091B1 (ar) مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
UY34306A (es) Pirimidinas condensadas sustituidas y su uso
CO6382125A2 (es) Inhibidores de proteína quinasa
BR112014000268A2 (pt) pirazolopiridinas com substituinte heteroarilo e utilização destas
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
AR087107A1 (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
MX349254B (es) Compuestos para el tratamiento del sindrome metabolico.
ECSP12011703A (es) Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos
BR112014031091A2 (pt) Derivados de piperidina para agonista de gpr119
CR20130693A (es) Composición farmacéutica ortalmológica tópica que contiene regorafenib
MX2014003701A (es) Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio.
AR084832A1 (es) Derivado cristalino de oxazina
JP2017517574A5 (https=)
AR085736A1 (es) Compuestos de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro